REPLIGEN CORP - COMMON STOCK (RGEN)

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,222,082
Number of holders
183
Total 13F shares, excl. options
30,095,607
Shares change
-406,725
Total reported value, excl. options
$838,161,582
Value change
-$17,473,045
Put/Call ratio
51%
Number of buys
108
Number of sells
-71
Price
$27.85

Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q3 2015

206 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q3 2015.
REPLIGEN CORP - COMMON STOCK (RGEN) has 183 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 30,095,607 shares of 56,222,082 outstanding shares and own 54% of the company stock.
Largest 10 shareholders include FMR LLC (2,606,473 shares), BlackRock Fund Advisors (2,434,572 shares), Invesco Ltd. (1,958,114 shares), RS INVESTMENT MANAGEMENT CO LLC (1,411,394 shares), OPPENHEIMER FUNDS INC (1,402,830 shares), VANGUARD GROUP INC (1,344,881 shares), STATE STREET CORP (1,286,921 shares), DIMENSIONAL FUND ADVISORS LP (1,232,678 shares), RENAISSANCE TECHNOLOGIES LLC (874,790 shares), and WELLS FARGO & COMPANY/MN (841,508 shares).
This table shows the top 183 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.